跳到主要內容

臺灣博碩士論文加值系統

(44.212.94.18) 您好!臺灣時間:2023/12/11 23:00
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:黃世鐘
研究生(外文):Shih-Chung Huang
論文名稱:鳶尾素對傷口癒合和心肌缺血的治療潛力
論文名稱(外文):The therapeutic potential of irisin for wound healing and myocardial ischemia
指導教授:戴明泓
指導教授(外文):Ming-Hong Tai
學位類別:博士
校院名稱:國立中山大學
系所名稱:生物醫學研究所
學門:生命科學學門
學類:生物化學學類
論文種類:學術論文
論文出版年:2019
畢業學年度:107
語文別:英文
論文頁數:114
中文關鍵詞:心肌缺血血管生成糖尿病傷口癒合鳶尾素含纖連蛋白III型結構域的蛋白5
外文關鍵詞:Myocardial ischemiaDiabetic wound healingAngiogenesisIrisinFibronectin Type III Domain Containing 5 (FNDC5)
相關次數:
  • 被引用被引用:0
  • 點閱點閱:151
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
眾所周知,這項運動有益於健康,降低患心血管疾病和糖尿病的風險。此外,運動可使心肌梗塞患者的心臟病死亡率降低26%。肌動蛋白是生物體中重要的細胞因子,其主要在運動後從肌肉細胞分泌。其功能可促進血管生成,修復和再生組織,維持身體的正常功能,影響免疫調節,並涉及許多全身性疾病的慢性炎症。 2012年,Boströmet發現了一種名為FNDC5的肌肉細胞因子,他們聲稱FNDC5表達引發一系列事件,裂解為最終產物為Irisin,導致白脂肪“褐變”。然而,由於當時ELISA試劑對於檢測Irisin專一性不高,因此該發現被懷疑其真實性。這疑問最終被Spiegelma的串聯質譜法驗證。此後,關於Irisin的大量論文在世界範圍內發表,其中一個研究機構被發現其對血管生成的影響及其對糖尿病和心血管疾病的可能有益作用。Fei Wu等的結果表明它可以誘導人臍靜脈內皮細胞的細胞增殖,遷移和管形成。在Tg(fli-1:EGFP)y1斑馬魚試驗中,它對血管生成具有顯著影響。然而,目前對於血管內皮生長因子(VEGF)和(缺氧誘導因子1α)HIF-1α參與Irisin功能過程的研究較少。此外,Irisin在糖尿病傷口癒合中應用的效果或減輕心肌損傷的途徑仍然不確定。因此,我們使用從大腸桿菌中表達和純化的重組FNDC5 / Irisin來驗證它們在大鼠糖尿病傷口癒合和心肌缺血性灌注模型中的功能,並闡明了我們的新發現。
It is well known that exercise is good for health and reduces the risk of cardiovascular disease and diabetes. In addition, exercise can reduce cardiac mortality by 26% among people who have experienced myocardial infarction. Myokines are important cytokines in organisms and are a major secretion from muscle cells after exercise. They can promote angiogenesis, repair and regenerate tissue, preserve normal functions of the body, affect immune modulation, and are involved in chronic inflammation in many systemic diseases. In 2012, Boström et al. found a new myokine called FNDC5, and they claimed that its expression in muscle triggers a sequence of events that lead to its trans-membrane cleavage with a final product of irisin, which causes the “browning” of fat. However, this finding has been doubted because the commercial ELISA kits used were not specified for the detection of irisin. The evidence was finally verified using tandem mass spectrometry by Spiegelman. Since then, numerous papers regarding irisin have been published worldwide, and some have found that it has an effect on angiogenesis is possibly beneficial for diabetes and cardiovascular diseases. Wu et al. showed that it can induce cell proliferation, migration, and tube formation in human umbilical vein endothelial cells. In a Tg (fli-1:EGFP)y1 zebrafish assay, it had a significant effect on angiogenesis. However, there is little study on whether vascular endothelial growth factor (VEGF) and hypoxia inducible factor 1α (HIF-1α) are involved in the functional process of irisin. Moreover, it remains uncertain what the effects of irisin are in diabetic wound healing or the pathway to attenuate the myocardial injury. Therefore, we used recombinant FNDC5/irisin expressed and purified from E. coli to determine its function in a model of diabetic wound healing and ischemic perfusion model using rats.
論文審定書 i
摘要 ii
Abstract iv
Chapter 1. FNDC5 therapy for diabetic wound healing 1
1.1 Introduction 2
1.2 Material and methods 4
1.3 Results 7
1.4 Discussion 9
1.5 Figures and legends 12
Chapter 2. The role of irisin in proangiogenic pathways including VEGF and nitric oxide signaling in endothelial cells 16
2.1 Introduction 17
2.2 Materials and methods 20
2.3 Results 29
2.4 Discussion 34
2. 5 Figures and legends 38
Chapter 3. The role of irisin in myocardial protection 53
3.1 Introduction 54
3.2 Materials and methods 56
3.3 Results 58
3.4 Discussion 63
3. 5 Figures and legends 65
Conclusion 74
References 77
Appendix 85
1.Chipkin SR, Klugh SA, Chasan-Taber L. Exercise and diabetes. Cardiol Clin 2001;19:489-505.
2.Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001;345:790-797.
3.Shoukry A, Shalaby SM, El-Arabi Bdeer S, Mahmoud AA, Mousa MM, Khalifa A. Circulating serum irisin levels in obesity and type 2 diabetes mellitus. IUBMB Life 2016;68:544-556.
4.Agren MS, Mertz PM, Franzen L. A comparative study of three occlusive dressings in the treatment of full-thickness wounds in pigs. J Am Acad Dermatol 1997;36:53-58.
5.De Vries HJ, Zeegelaar JE, Middelkoop E, Gijsbers G, Van Marle J, Wildevuur CH, Westerhof W. Reduced wound contraction and scar formation in punch biopsy wounds. Native collagen dermal substitutes. A clinical study. Br J Dermatol 1995;132:690-697.
6.Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci 2002;115:3861-3863.
7.Williams CM, Engler AJ, Slone RD, Galante LL, Schwarzbauer JE. Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation. Cancer Res 2008;68:3185-3192.
8.Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012;481:463-468.
9.Schumacher MA, Chinnam N, Ohashi T, Shah RS, Erickson HP. The structure of irisin reveals a novel intersubunit beta-sheet fibronectin type III (FNIII) dimer: implications for receptor activation. J Biol Chem 2013;288:33738-33744.
10.Walton DM, Minton SD, Cook AD. The potential of transdermal nitric oxide treatment for diabetic peripheral neuropathy and diabetic foot ulcers. Diabetes Metab Syndr 2018.
11.Henriksen T, Green C, Pedersen BK. Myokines in myogenesis and health. Recent Pat Biotechnol 2012;6:167-171.
12.Puigserver P. Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha. Int J Obes (Lond) 2005;29 Suppl 1:S5-9.
13.Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Belen Crujeiras A, Seoane LM, et al. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One 2013;8:e60563.
14.Song H, Wu F, Zhang Y, Zhang Y, Wang F, Jiang M, Wang Z, et al. Irisin promotes human umbilical vein endothelial cell proliferation through the ERK signaling pathway and partly suppresses high glucose-induced apoptosis. PLoS One 2014;9:e110273.
15.Egginton S. Invited review: activity-induced angiogenesis. Pflugers Arch 2009;457:963-977.
16.Li F, Chong ZZ, Maiese K. Winding through the WNT pathway during cellular development and demise. Histol Histopathol 2006;21:103-124.
17.Bee YS, Sheu SJ, Ma YL, Lin HC, Weng WT, Kuo HM, Hsu HC, et al. Topical application of recombinant calreticulin peptide, vasostatin 48, alleviates laser-induced choroidal neovascularization in rats. Mol Vis 2010;16:756-767.
18.Yang X, Cui W, Yu S, Xu C, Chen G, Gu A, Li T, et al. A synthetic dl-nordihydroguaiaretic acid (Nordy), inhibits angiogenesis, invasion and proliferation of glioma stem cells within a zebrafish xenotransplantation model. PLoS One 2014;9:e85759.
19.Proulx K, Lu A, Sumanas S. Cranial vasculature in zebrafish forms by angioblast cluster-derived angiogenesis. Dev Biol 2010;348:34-46.
20.Roman BL, Pham VN, Lawson ND, Kulik M, Childs S, Lekven AC, Garrity DM, et al. Disruption of acvrl1 increases endothelial cell number in zebrafish cranial vessels. Development 2002;129:3009-3019.
21.Kuo HM, Lin CY, Lam HC, Lin PR, Chan HH, Tseng JC, Sun CK, et al. PTEN overexpression attenuates angiogenic processes of endothelial cells by blockade of endothelin-1/endothelin B receptor signaling. Atherosclerosis 2010;221:341-349.
22.Ma YL, Lin SW, Fang HC, Chou KJ, Bee YS, Chu TH, Chang MC, et al. A novel poly-naphthol compound ST104P suppresses angiogenesis by attenuating matrix metalloproteinase-2 expression in endothelial cells. Int J Mol Sci 2014;15:16611-16627.
23.Tai MH, Kuo SM, Liang HT, Chiou KR, Lam HC, Hsu CM, Pownall HJ, et al. Modulation of angiogenic processes in cultured endothelial cells by low density lipoproteins subfractions from patients with familial hypercholesterolemia. Atherosclerosis 2006;186:448-457.
24.Lee MY, Wang Y, Vanhoutte PM. Senescence of cultured porcine coronary arterial endothelial cells is associated with accelerated oxidative stress and activation of NFkB. J Vasc Res 2010;47:287-298.
25.Giustarini D, Rossi R, Milzani A, Dalle-Donne I. Nitrite and nitrate measurement by Griess reagent in human plasma: evaluation of interferences and standardization. Methods Enzymol 2008;440:361-380.
26.Prior BM, Yang HT, Terjung RL. What makes vessels grow with exercise training? J Appl Physiol (1985) 2004;97:1119-1128.
27.Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005;438:967-974.
28.Boulton AJ. The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes Metab Res Rev 2008;24 Suppl 1:S3-6.
29.Wu F, Song H, Zhang Y, Zhang Y, Mu Q, Jiang M, Wang F, et al. Irisin Induces Angiogenesis in Human Umbilical Vein Endothelial Cells In Vitro and in Zebrafish Embryos In Vivo via Activation of the ERK Signaling Pathway. PLoS One 2015;10:e0134662.
30.Hoeppner LH, Sinha S, Wang Y, Bhattacharya R, Dutta S, Gong X, Bedell VM, et al. RhoC maintains vascular homeostasis by regulating VEGF-induced signaling in endothelial cells. J Cell Sci 2015;128:3556-3568.
31.Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003;9:1370-1376.
32.Sheng ZL, Yao YY, Li YF, Fu C, Ma GS. Transplantation of bradykinin-preconditioned human endothelial progenitor cells improves cardiac function via enhanced Akt/eNOS phosphorylation and angiogenesis. Am J Transl Res 2015;7:1045-1057.
33.Everaert BR, Van Craenenbroeck EM, Hoymans VY, Haine SE, Van Nassauw L, Conraads VM, Timmermans JP, et al. Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway. Int J Cardiol 2010;144:350-366.
34.Fu J, Han Y, Wang J, Liu Y, Zheng S, Zhou L, Jose PA, et al. Irisin Lowers Blood Pressure by Improvement of Endothelial Dysfunction via AMPK-Akt-eNOS-NO Pathway in the Spontaneously Hypertensive Rat. J Am Heart Assoc 2016;5.
35.Bunik VI, Schloss JV, Pinto JT, Dudareva N, Cooper AJ. A survey of oxidative paracatalytic reactions catalyzed by enzymes that generate carbanionic intermediates: implications for ROS production, cancer etiology, and neurodegenerative diseases. Adv Enzymol Relat Areas Mol Biol 2011;77:307-360.
36.Mesarwi OA, Shin MK, Bevans-Fonti S, Schlesinger C, Shaw J, Polotsky VY. Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease. PLoS One 2016;11:e0168572.
37.Rosmorduc O, Housset C. Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease. Semin Liver Dis 2010;30:258-270.
38.Burgueno AL, Gianotti TF, Mansilla NG, Pirola CJ, Sookoian S. Cardiovascular disease is associated with high-fat-diet-induced liver damage and up-regulation of the hepatic expression of hypoxia-inducible factor 1alpha in a rat model. Clin Sci (Lond) 2013;124:53-63.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top